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Abstract
Convolutional Neural Networks (CNNs) are a popular deep learning architecture
widely applied in different domains, in particular in classifying over images, for
which the concept of convolution with a filter comes naturally. Unfortunately, the
requirement of a distance (or, at least, of a neighbourhood function) in the input
feature space has so far prevented its direct use on data types such as omics data.
However, a number of omics data are metrizable, i.e., they can be endowed with a
metric structure, enabling to adopt a convolutional based deep learning framework,
e.g., for prediction. We propose a generalized solution for CNNs on omics data,
implemented through a dedicated Keras layer. In particular, for metagenomics data,
a metric can be derived from the patristic distance on the phylogenetic tree. For
transcriptomics data, we combine Gene Ontology semantic similarity and gene
co-expression to define a distance; the function is defined through a multilayer
network where 3 layers are defined by the GO mutual semantic similarity while the
fourth one by gene co-expression. As a general tool, feature distance on omics data
is enabled by OmicsConv, a novel Keras layer, obtaining OmicsCNN, a dedicated
deep learning framework. Here we demonstrate OmicsCNN on gut microbiota
sequencing data, for Inflammatory Bowel Disease (IBD) 16S data, first on synthetic
data and then a metagenomics collection of gut microbiota of 222 IBD patients.
1 Introduction
The diversity and the complex structure of biological data represent both a challenge and an opportu-
nity Deep Learning (DL) techniques [1]. In fact, the superiority of deep neural network approaches is
demonstrated on a growing number of biological and clinical tasks [2, 3, 4]. Nonetheless, the DL
potential is clearly being limited on omics data: open issues are transversal to other domains, e.g.,
limited availability of data, interpretability, hyperparameters tuning [5], but overall there is a need
for architectures designed to use biological knowledge and underlying structure. As a consequence,
the direct application of deep networks to microarray, genetic or other omics can be disappointing,
as found by Ditzler and coauthors [6] that claimed that deep learning ”may not be suitable for
metagenomic application”.
In order to bridge this gap, we propose a short path to the application of Convolutional Neural Network
(CNNs) architectures to omics data. CNNs is the elective solution for image classification [7, 8],
based on convolving subsets of the input image with different filters, where the key concept is the
definition of a set of nearest neighbours for a given pixel. Using the same architecture for non-image
data requires the availability of an analogous proximity measure between features.
As a first step, we show how to embed omics data in a metric space: in particular, we consider the
case of metagenomics and transcriptomics. In the former case, the metric is a tree distance on the
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Figure 1: The structure of OmicsCNN. In this configuration, OmicsCNN is composed by two
OmicsConv layers followed by a Fully Connected layer before decision.
phylogenetic tree, while in the latter case we propose a more complex structure based on the diffusion
distance on a 4 layers multilayer network [9]. Given the distance, the neighbour detection comes
naturally. The convolutional layer combined with the neighbours detection algorithm is operatively
implemented as a novel Keras layer [10] called OmicsConv. The overall architecture OmicsCNN
then consists of a stack of OmicsConv layers first flattened then terminating with a Fully Connected
(Dense) and a final classification layer. The environment is completed by an experimental setup
for unbiased prediction, i.e., a 10×5-fold Data Analysis Protocol (DAP) developed for unbiased
biomarker identification within the US-FDA led initiatives MAQC/SEQC [11, 12].
As a case study, we conclude with a comparison of the OmicsCNN DAP on the metagenomics IBD
dataset [13] with other classical and DL algorithm, where the OmicsCNN is applied in a domain
adaptation strategy, freezing the first layers after they have been trained on a large synthetic dataset.
Further details on the metagenomics case are described in [14].
2 Metrizing omics data
Differently from images, a natural distance between features is not immediately defined for most of
omics data types. Although an indirect transformation into images of outcomes from sequencing has
been proposed, we seek here to start a principled development of methods that can apply to some of
the most interesting omics data types for clinical application and scientific discovery.
Metagenomics data are usually described in terms of operational taxonomic units (OTUs), a general
definition to identify groups of closely related individuals (e.g. species, genus, . . . ). OTUs have a
well-defined structure and this provides our first example because a proximity measure can indeed be
inherited by the tree structure connecting the OTUs. In general terms any tree distance can be chosen
as base metric for the convolution functions; here we demonstrate our approach on the patristic
distance (see Fig. 2(a)), i.e., the sum of the lengths of all branches connecting two OTUs on the
phylogenetic tree [15].
Our second domain is transcriptomic data, i.e. gene expression, for which several definitions of
distances between two genes have been proposed. Most of such definitions are taking into account
the genetic distance on the genome, or statistics of the gene expression. We need to add that the
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Figure 2: (a) Patristic distance on a tree; (b) Diffusion distance for every layer of the multilayer
networks for transcriptomics data: the four layers are Absolute Pearson Correlation Coefficient
(APCC) and the three Gene Ontology layers Cellular Component (CC), Molecular Function (MF)
and Biological Process (BP).
very fast development of biology of regulation [16] and about the implication of chromatin structure
on gene expression [17], and most recent findings in measuring differences across cell types and
functions [18] make gene expression metrization a moving target. In particular, experiments are
currently running on both microarray and RNA-Seq data, with the MAQCII/SEQC Neuroblastoma
dataset [19, 20] (498 samples on both platforms) as the first testbed. Here we propose a principled
metric for gene expression, relying on the mathematics of multilayer networks [21]. The metrics can
be applied to other omics data types, and extended to deal with integration. In details, a multilayer
undirected weighted network on shared vertices (i.e., an edge-colored graph) is built with genes as
the nodes. This graph includes 4 layers: in the first layer, two nodes are connected by an edge if the
absolute Pearson correlation between the expression across all samples of the corresponding genes is
larger than a significance threshold; in this case, the weight of the edge is given by the absolute value
of the correlation coefficient. The other three layers are built according to the three categories of
the Gene Ontology, i.e., cellular component, molecular function and biological process [22, 23]. In
each layer, a link connects two genes if their semantic similarity (e.g. as defined by GOSemSim [24])
is not null, and the edge weight is exaclty this non-zero value. Given this multilayer structure, the
metric between two genes on each layer is given by the diffusion distance [9] (see Fig. 2(b)), which
quantifies the likelihood that two random walkers originating in the two genes meet in some other
node of the net. The overall distance in the network is given by the L2 Euclidean product of the
diffusion distances of each layer.
Once a omics distance is defined, the concept of nearest neighbours among features comes straightfor-
wardly and the CNN algorithm can be applied. However, by definition, the output of a CNN consists
of linear combinations of the original input features: this implies that, after the first CNN layer, the
problem of finding the neighbours of a feature becomes the hardest task of finding the neighbours of a
linear combination of features. We thus propose to map features into points of a k-dimensional metric
space preserving distances as well as possible via a MultiDimensional Scaling (MDS) projection [25],
which can be applied if the starting distance is Euclidean. A further refinement is provided by
sparsifying MDS via regularized low rank matrix approximation [26] through the addition of the
smoothly clipped absolute deviation penalty [27], tuned by cross-validation.
3 OmicsCNN and experimental setup
The convolutional layer combined with the neighbours detection algorithm is operatively implemented
as a novel Keras layer [10] called OmicsConv, which convolves the selected neighbours with the
filters. In our metagenomics case study, the number of neighbours and the number of filters are
both set to 16. In a generic OmicsConv layer, the structure input is represented by a collection of
metafeatures, i.e. linear combinations of the original features; the first OmicsConv layer has the
original set of features as input. The OmicsConv is then repeated; finally, the terminating layers of the
OmicsCNN are a MaxPooling, then a Flatten layer and, finally, a Fully Connected with 128 neurons
and a 0.25 Dropout. Each convolutional layer has a Scaled Exponential Linear Units (SELU) [28] as
the activation fuction,and the dense layer in transfer learning experiments uses a sigmoid activation
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Figure 3: Data Analysis Protocol for the experimental framework.
function. Adam [29] is used as optimizer with learning rate 0.0005. The global learning architecure
is called OmicsCNN, shown in Fig. 1.
To ensure predictive power and limit overfitting effect, the experimental framework is structured
following the guidelines recommended by the US-FDA led studies MAQC/SEQC [11, 12] that
investigated the development of predictive models for the analysis of high-throughput data. The
experimental setup is realized as a 10×5-fold cross-validation schema with a feature selection and
ranking procedure, implementing a Data Analysis Protocol (DAP) to control for selection bias
and other overfitting effects and warranting honest performance estimates on external validation
data subsets. Top ranking features are recursively selected as the k-best at each round, and finally
aggregated via Borda algorithm [30]. Model performance is computed for increasing number of best
ranking features by Matthews Correlation Coefficient (MCC), the measure that better convey in an
unique value the confusion matrix of a classification task, even in the multiclass case [31, 32, 33, 34].
Experiments with randomized features and labels are also performed as model sanity check.
The OmicsCNN is implemented as a Keras v2.0.8 layer, while the whole DAP is written in
Python/Scikit-Learn. All computations were run on a Microsoft Azure platform with 2x NVIDIA
Tesla K80 GPUs. A first version of the architecture, dedicated to metagenomics application, together
with the IBD and synthetic metagenomics datasets are available at https://gitlab.fbk.eu/
MPBA/phylogenetic-cnn.
4 Case study
Sokol’s lab data [13] collects microbiome information with 16S sequencing for 38 healthy subjects
(HS) and 222 inflammatory bowel disease (IBD) patients. The bacterial composition was analysed
using 16S sequencing and a total number of 306 different OTUs was found. IBD is a complex disease
arising as a result of the interaction of environmental and genetic factors inducing immunological
responses and inflammation in the intestine and primarily including ulcerative colitis (UC) and
Crohn’s disease (CD). Both disease classes are characterized by two conditions: flare (f), when
symptoms reappear or worsen, and remission (r), when symptoms are reduced or disappear. Finally,
since CD can affect different parts of the intestine, we distinguish ileal Crohn’s disease (iCD) and
colon Crohn’s disease (CD). Note however,that the number of non zero features varies for the different
rom tasks to task, (defined by disease, condition site) since some features may vanish on all samples
of a class. Due to the paucity of samples preventing an effective deep learning training phase, a
synthetic dataset D was generated to be used as the training set for the domain adaptation task.
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Table 1: Dataset D on IBD: classification performances of OmicsCNN compared to other classifiers
on the external validation dataset.
Task OmicsCNN LSVM MLPNN RF
UCf 0.741 0.740 0.666 0.699
UCr 0.583 0.497 0.608 0.678
CDf 0.858 0.642 0.705 0.707
CDr 0.853 0.654 0.654 0.597
iCDf 0.842 0.418 0.401 0.920
iCDr 0.628 0.414 0.414 0.418
Operatively, D is generated as compositional data whose structure resembles the IBD data, sampling
10000 points from multivariate normal distributions with given covariances and mean.
OmicsCNN is first trained on the synthetic dataset D, then all layers but the last one are freezed, the
last layer is substituted by a 2-neurons Dense layer and then retrained on the IBD dataset. The full
DAP is then applied to the IBD datasets, comparing the performance with standard (and shallow)
learning algorithms such as linear Support Vector Machines (SVM) and Random Forest (RF), and
with a standard Multi Layer Perceptron (MLPNN) [35], obtaining the results listed in Tab. 1.
OmicsCNN achieves better results in 4 tasks out of 6, with interesting improvements in the hardest
CD/iCD tasks, suggesting even better outcomes are to be expected with more intensive optimization
of the components of the proposed OmicsCNN architecture.
5 Conclusions
We introduced here the first steps towards a global plan of making CNNs available to a number of
(omics) data types by defining theoretically grounded embedding of features into metric spaces to ac-
tivate a nearest neighbour function. Encouraging initial results on metagenomics and transcriptomics
support further investigations and extension to other metrizable omics structures.
References
[1] T. Ching, D. S. Himmelstein, B. K. Beaulieu-Jones, A. A. Kalinin, B. T. Do, G. P. Way,
E. Ferrero, P.-M. Agapow, W. Xie, G. L. Rosen, B. J. Lengerich, J. Israeli, J. Lanchantin,
S. Woloszynek, A. E. Carpenter, A. Shrikumar, J. Xu, E. M. Cofer, D. J. Harris, D. DeCaprio,
Y. Qi, A. Kundaje, Y. Peng, L. K. Wiley, M. H. S. Segler, A. Gitter, and C. S. Greene. Op-
portunities And Obstacles For Deep Learning In Biology And Medicine. bioRxiv 142760,
2017.
[2] P. Mamoshina, A. Vieira, E. Putin, and A. Zhavoronkov. Applications of Deep Learning in
Biomedicine. Molecular Pharmaceutics, 13(5):1445–1454, 2016.
[3] K. Chaudhary, O. B. Poirion, L. Lu, and L. Garmire. Deep Learning based multi-omics
integration robustly predicts survival in liver cancer. bioRxiv 114892, 2017.
[4] E. I. Zacharaki. Prediction of protein function using a deep convolutional neural network
ensemble. PeerJ Computer Science, 3:e124, 2017.
[5] S. Min, B. Lee, and S. Yoon. Deep learning in bioinformatics. Briefings in Bioinformatics,
Advance Access 29 June 2016:bbw068, 2016.
[6] G. Ditzler, R. Polikar, and G. Rosen. Multi-Layer and Recursive Neural Networks for Metage-
nomic Classification. IEEE Transactions on NanoBioscience, 14(6):608–616, 2015.
[7] Y. LeCun, L. Bottou, Y. Bengio, and P. Haffner. Gradient-based learning applied to document
recognition. Proceedings of the IEEE, 86(11):2278–2324, 1998.
[8] A. Krizhevsky, I. Sutskever, and G. E. Hinton. ImageNet Classification with Deep Convolutional
Neural Networks. In F. Pereira, C. J. C. Burges, L. Bottou, and K. Q. Weinberger, editors,
Advances in Neural Information Processing Systems, volume 25, pages 1097–1105. Curran
Associates, Inc., 2012.
5
[9] M. De Domenico. Diffusion geometry unravels the emergence of functional clusters in collective
phenomena. Physical Review Letters, 118(16):168301, 2017.
[10] F. Chollet. Keras. https://github.com/fchollet/keras, 2015.
[11] The MicroArray Quality Control (MAQC) Consortium. The MAQC-II Project: A compre-
hensive study of common practices for the development and validation of microarray-based
predictive models. Nature Biotechnology, 28(8):827–838, 2010.
[12] The SEQC/MAQC-III Consortium. A comprehensive assessment of RNA-seq accuracy, re-
producibility and information content by the Sequencing Quality Control Consortium. Nature
Biotechnology, 32(9):903–914, 2014.
[13] H. Sokol, V. Leducq, H. Aschard, H.-P. Pham, S. Jegou, C. Landman, D. Cohen, G. Liguori,
A. Bourrier, I. Nion-Larmurier, J. Cosnes, P. Seksik, P. Langella, D. Skurnik, M. L. Richard,
and L. Beaugerie. Fungal microbiota dysbiosis in IBD. Gut, 66(6):1039–1048, 2017.
[14] D. Fioravanti, Y. Giarratano, V. Maggio, C. Agostinelli, M. Chierici, G. Jurman,
and C. Furlanello. Phylogenetic Convolutional Neural Networks in Metagenomics.
arXiv:1709.02268, submitted, 2017.
[15] T. F. Stuessy and C. König. Patrocladistic classification. Taxonomy, 57(2):594–601, 2008.
[16] The FANTOM Consortium and the RIKEN PMI and CLST (DGT). A promoter-level mam-
malian expression atlas. Nature, 507(7493):462–470, 2014.
[17] R. Singh, J. Lanchantin, G. Robins, and Y. Qi. DeepChrome: deep-learning for predicting gene
expression from histone modifications. Bioinformatics, 32(17):i639–i648, 2016.
[18] GTEx Consortium, Lead analysts, Laboratory, Data Analysis & Coordinating Center (LDACC),
NIH program management, Biospecimen collection, Pathology, eQTL manuscript working
group, A. Battle, C. D. Brown, B. E. Engelhardt, and S. B. Montgomery. Genetic effects on
gene expression across human tissues. Nature, 550(7675):204–213, 2017.
[19] W. Zhang, Y. Yu, F. Hertwig, J. Thierry-Mieg, W. Zhang, D. Thierry-Mieg, J. Wang,
C. Furlanello, V. Devanarayan, J. Cheng, Y. Deng, B. Hero, H. Hong, M. Jia, L. Li, S.M. Lin,
Y. Nikolsky, A. Oberthuer, T. Qing, Z. Su, R. Volland, C. Wang, M.D. Wang, J. Ai, D. Albanese,
S. Asgharzadeh, S. Avigad, W. Bao, M. Bessarabova, M.H. Brilliant, B. Brors, M. Chierici,
T.-M. Chu, J. Zhang, R.G. Grundy, M.M. He, S. Hebbring, H.L. Kaufman, S. Lababidi, L.J.
Lancashire, Y. Li, X.X. Lu, H. Luo, X. Ma, B. Ning, R. Noguera, M. Peifer, J.H. Phan, F. Roels,
C. Rosswog, S. Shao, J. Shen, J. Theissen, G.P. Tonini, J. Vandesompele, P.-Y. Wu, W. Xiao,
J. Xu, W. Xu, J. Xuan, Y. Yang, Z. Ye, Z. Dong, K.K. Zhang, Y. Yin, C. Zhao, Y. Zheng, R.D.
Wolfinger, T. Shi, L.H. Malkas, F. Berthold, J. Wang, W Tong, L. Shi, Z. Peng, and M. Fischer.
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction. Genome
Biology, 16(1):133, 2015.
[20] A. Oberthuer, D. Juraeva, B. Hero, R. Volland, C. Sterz, R. Schmidt, A. Faldum, Y. Kahlert,
A. Engesser, S. Asgharzadeh, R. Seeger, M. Ohira, A. Nakagawara, P. Scaruffi, G.P. Tonini,
I. Janoueix-Lerosey, O. Delattre, G. Schleiermacher, J. Vandesompele, F. Speleman, R. Noguera,
M. Piqueras, J. Bénard, A. Valent, S. Avigad, I. Yaniv, R.G. Grundy, M. Ortmann, C. Shao,
M. Schwab, R. Eils, T. Simon, J. Theissen, F. Berthold, F. Westermann, B. Brors, and M. Fis-
cher. Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk
Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers. Clinical
Cancer Research, 21(8):1904–1915, 2015.
[21] M. Kivelä, A. Arenas, M. Barthelemy, J. P. Gleeson, Y. Moreno, and M. A. Porter. Multilayer
networks. Journal of Complex Networks, 2(3):203–271, 2014.
[22] M. Ashburner, C. A. Ball, J. A. Blake, D. Botstein, H. Butler, J. M. Cherry, A .P. Davis,
K. Dolinski, S. S.. Dwight, J. T.. Eppig, M. A. Harris, D. P.. Hill, L. Issel-Tarver, A. Kasarskis,
S. Lewis, J. C. Matese, J. E. Richardson, M. Ringwald, G. M. Rubin, and G. Sherlock. Gene
Ontology: tool for the unification of biology. Nature Genetics, 25(1):25–29, 2000.
[23] The Gene Ontology Consortium. Expansion of the Gene Ontology knowledgebase and resources.
Nucleic Acid Research, 45(D1):D331–D338, 2017.
[24] G. Yu, F. Li, Y. Qin, X. Bo, Y. Wu, and S. Wang. GOSemSim: an R package for measuring
semantic similarity among GO terms and gene products. Bioinformatics, 26(7):976–978, 2010.
[25] T. F. Cox and M. A. A. Cox. Multidimensional Scaling. Chapman and Hall, 2001.
6
[26] H. Shen and J. Z. Huang. Sparse principal componenent analysis via regularized low rank
matrix approximation. Journal of Multivariate Analysis, 99:1015–1034, 2007.
[27] J. Fan and R. Li. Variable selection via nonconcave penalized likelihood and its oracle properties.
Journal of the American Statistical Association, 96:1348–1360, 2001.
[28] G. Klambauer, T. Unterthiner, A. Mayr, and S. Hochreiter. Self-Normalizing Neural Networks.
arXiv:1706.02515, 2017.
[29] D. Kingma and J. Ba. Adam: A Method for Stochastic Optimization. arXiv:1412.6980; 3rd
International Conference for Learning Representations, ICLR 2015, 2014.
[30] G. Jurman, S. Riccadonna, R. Visintainer, and C. Furlanello. Algebraic Comparison of Partial
Lists in Bioinformatics. PLOS ONE, 7(5):e36540, 2012.
[31] B.W. Matthews. Comparison of the predicted and observed secondary structure of T4 phage
lysozyme. Biochimica et Biophysica Acta - Protein Structure, 405(2):442–451, 1975.
[32] P. Baldi, S. Brunak, Y. Chauvin, C.A.F. Andersen, and H. Nielsen. Assessing the accuracy of
prediction algorithms for classification: an overview. Bioinformatics, 16(5):412–424, 2000.
[33] J. Gorodkin. Comparing two K-category assignments by a K-category correlation coefficient.
Computational Biology and Chemistry, 28:367–374, 2004.
[34] G. Jurman, S. Riccadonna, and C. Furlanello. A comparison of MCC and CEN error measures
in multi-class prediction. PLOS ONE, 7(8):e41882, 2012.
[35] C. M. Bishop. Neural Networks for Pattern Recognition. Oxford University Press, 1995.
7
